Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enalapril strategies for prevention of anthracycline-induced cardiotoxicity
2012-002248-26Phase 3Completed
- Sponsor
- European Institute of Oncology
- Start
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of enalapril in Anthracycline Cardiomyopathy, sponsored by European Institute of Oncology. Started Sep 2012; status: completed.
02
Drugs
enalapril
03
Conditions
Anthracycline Cardiomyopathy
Beyond the preview
Go deeper on 2012-002248-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002248-26.